Sirona Biochem Corp. (SRBCF)
OTCMKTS
· Delayed Price · Currency is USD
0.0186
0.00 (0.00%)
Apr 28, 2025, 4:00 PM EDT
Sirona Biochem Income Statement
Financials in millions CAD. Fiscal year is November - October.
Millions CAD. Fiscal year is Nov - Oct.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2014 - 2018 |
---|---|---|---|---|---|---|---|
Period Ending | Jul '24 Jul 31, 2024 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 | Oct '21 Oct 31, 2021 | Oct '20 Oct 31, 2020 | Oct '19 Oct 31, 2019 | 2014 - 2018 |
Operating Revenue | -0.02 | 0.03 | 0.67 | 0.27 | 0.11 | 0.14 | Upgrade
|
Revenue | -0.02 | 0.03 | 0.67 | 0.27 | 0.11 | 0.14 | Upgrade
|
Revenue Growth (YoY) | - | -94.82% | 150.70% | 153.54% | -22.12% | -89.38% | Upgrade
|
Cost of Revenue | 0.07 | 0.06 | 0.05 | 0.07 | 0.05 | - | Upgrade
|
Gross Profit | -0.08 | -0.03 | 0.62 | 0.2 | 0.05 | 0.14 | Upgrade
|
Selling, General & Admin | 1.08 | 1.25 | 1.65 | 1.06 | 1.16 | 2.01 | Upgrade
|
Research & Development | 0.9 | 0.99 | 0.89 | 0.93 | 1.25 | 1.26 | Upgrade
|
Operating Expenses | 2.18 | 2.28 | 4.01 | 2.33 | 4.05 | 4.33 | Upgrade
|
Operating Income | -2.27 | -2.31 | -3.39 | -2.13 | -4 | -4.2 | Upgrade
|
Interest Expense | -0.4 | -0.2 | -0.03 | -0 | -0.01 | -0.12 | Upgrade
|
Interest & Investment Income | - | - | - | - | - | 0.03 | Upgrade
|
Currency Exchange Gain (Loss) | -0 | -0 | 0.01 | -0.02 | 0 | 0 | Upgrade
|
Other Non Operating Income (Expenses) | 0.01 | -0.03 | -0.14 | -0.15 | -0.13 | -0.27 | Upgrade
|
EBT Excluding Unusual Items | -2.66 | -2.54 | -3.55 | -2.31 | -4.14 | -4.56 | Upgrade
|
Pretax Income | -2.66 | -2.54 | -3.55 | -2.31 | -4.14 | -4.56 | Upgrade
|
Income Tax Expense | 0 | -0 | 0.01 | -0.01 | -0.01 | -0.01 | Upgrade
|
Net Income | -2.67 | -2.54 | -3.56 | -2.31 | -4.13 | -4.55 | Upgrade
|
Net Income to Common | -2.67 | -2.54 | -3.56 | -2.31 | -4.13 | -4.55 | Upgrade
|
Shares Outstanding (Basic) | 255 | 252 | 241 | 229 | 226 | 201 | Upgrade
|
Shares Outstanding (Diluted) | 255 | 252 | 241 | 229 | 226 | 201 | Upgrade
|
Shares Change (YoY) | 2.79% | 4.59% | 5.16% | 1.41% | 12.32% | 17.15% | Upgrade
|
EPS (Basic) | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 | -0.02 | Upgrade
|
EPS (Diluted) | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 | -0.02 | Upgrade
|
Free Cash Flow | -2.03 | -1.76 | -2.18 | -2.16 | -2.16 | -3.56 | Upgrade
|
Free Cash Flow Per Share | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 | Upgrade
|
Gross Margin | - | -82.71% | 92.53% | 74.34% | 48.79% | 100.00% | Upgrade
|
Operating Margin | - | -6649.66% | -504.45% | -796.37% | -3779.24% | -3093.19% | Upgrade
|
Profit Margin | - | -7312.43% | -529.50% | -860.50% | -3910.40% | -3351.61% | Upgrade
|
Free Cash Flow Margin | - | -5053.37% | -324.07% | -805.24% | -2042.43% | -2622.23% | Upgrade
|
EBITDA | -2.26 | -2.3 | -3.38 | -2.12 | -3.99 | - | Upgrade
|
D&A For EBITDA | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | - | Upgrade
|
EBIT | -2.27 | -2.31 | -3.39 | -2.13 | -4 | -4.2 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.